Angiotensin II type 1 receptor knockdown impairs interleukin-1β-induced cytokines in human periodontal fibroblasts
- Lilian Gobbo Gabriele,
- ,
- Thiago José Dionísio,
- Carlos Ferreira Santos(corresponding author)
- Universidade de São Paulo,
- University of the Pacific,
- Department of Biomedical Sciences,
- Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewAbstract
<p>Background: The renin-angiotensin (Ang) system (RAS) has been reported as an important modulator of inflammatory and immune responses. Evidence suggests an alternative Ang 1-7/Mas receptor axis as counter-regulatory to the classic RAS Ang II/Ang II Type 1 (AT1) receptor axis. It is known that periodontal pathogens elicit host-derived immune response due to release of cytokines such as interleukin (IL)-1β, and fibroblasts are among the most numerous sentinel cells that contribute to this production. The aim of this study is to determine whether AT1 receptor (AT1R) contributes to production of inflammatory cytokines that are important for periodontal pathogenesis using primary human gingival fibroblasts (HGFs) and human periodontal ligament fibroblasts (HPLFs) stimulated with IL-1β. Methods: Through RNA interference or pharmacologic inhibition using AT1R antagonist losartan, HGF and HPLF were stimulated by IL-1β for 3 (messenger RNA [mRNA]) or 24 (protein) hours. Results: IL-1β upregulated mRNA expression of AT1R, IL- 1β, IL-6, IL-8, tumor necrosis factor-alpha, and osteoprotegerin (OPG) in HGF and HPLF. AT1R knockdown impaired IL-1β-induced IL-6 and IL-8 secretion in cultured HGF and HPLF. AT1R silencing also increased OPG gene expression in HGF only. Pharmacologic inhibition of AT1R through losartan modulated mRNA transcription of IL-6 and IL-8 in HPLF but not in HGF. In contrast, IL-1β-induced secretion of IL-6 and IL-8 was not influenced by losartan in HGF or HPLF. Conclusion: These results suggest that AT1R knockdown and AT1R pharmacologic blockade by losartan may differently control balance of inflammatory cytokines, such as IL-6 and IL-8, in primary human periodontal fibroblasts.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages e1-e11Journal (Volume, Issue Number)
Journal of periodontology (Volume 88, Issue 1)Publication milestones
- Published - 01/2017
Publication status
Published - 01/2017
ISSN
0022-3492Publication IDs
- Scopus: 85007202907
- PubMed: 27541080
- ORCID: /0000-0003-4749-571X/work/107901291
Publication metrics
Metrics
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
25
Citation count
21
Usage
104
Funding Details
This work was supported by grants from São Paulo Research Foundation, São Paulo, Brazil (FAPESP, #2015/03965-2) and National Council for Scientificand Technological Development, Brazil (CNPq, #480160/2013-9 and #303494/2013-1) to Dr. Santos as well as post-doctoral scholarships (FAPESP, #2013/ 16113-9 and #2015/20954-4) to Dr. Morandini. All authors contributed equally to this article. The authors report no conflicts of interest related to this study.
FundersFunding numbers
National Council for Scientificand Technological Development
-São Paulo
-FAPESP
2015/03965-2
CNPq
2015/20954-4, 480160/2013-9, 303494/2013-1, 2013/ 16113-9
